Therapy Area topics

Cardiovascular

Central Nervous System

Diabetes

Vantage logo

Novo goes small with big Dicerna deal

Novo Nordisk takes its first step into RNA with a broad cardio-metabolic deal with Dicerna, the biggest sealed by the US biotech to date.

Digital Health

Oncology

Respiratory

Various

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.